Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity

see the original item page
in the repository's web site and access all digital files if the item*



Design and synthesis of 21-alkynylaryl pregnenolone derivatives and evaluation of their anticancer activity

Mavrofrydi O.
Pantzou A.
Szalóki G.
Προύσης, Κυριάκος
Papazafiri P.
Καλογεροπούλου, Θεοδώρα

Άρθρο σε επιστημονικό περιοδικό

2014


A series of novel C21-alkynylaryl derivatives of pregnenolone were synthesized and screened for anticancer activity against a panel of seven human cancer cell lines (LNCaP, A549, MCF7, HeLa, A431, HepG2, HT29). The data revealed that these compounds can be potential antitumour agents against the specific cell models. Compound 6f bearing a 2-trifluoromethylphenyl group displayed improved cytotoxicity towards all cancer cell lines used. A431 cells were the most sensitive with derivatives 6e-6h bearing electron withdrawing substituents exhibiting high potency with IC50 values ranging between 2.18 and 0.54 μM and drastic inhibition of the prosurvival PI3K-Akt/PKB pathway.

Φαρμακευτική χημεία (EL)
Pharmaceutical chemistry (EN)

Alkynylaryl derivatives (EN)
Anticancer activity (EN)
Pregnenolone (EN)

English

Elsevier Ltd


Bioorganic and Medicinal Chemistry

© 2014 Elsevier Ltd. All rights reserved.
© 2014 Elsevier Ltd. All rights reserved. (EN)




*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)